82 related articles for article (PubMed ID: 21517239)
1. Identification of pathways involved in paclitaxel activity in cervical cancer.
Qiao WJ; Cheng HY; Li CQ; Jin H; Yang SS; Li X; Zhang YY
Asian Pac J Cancer Prev; 2011; 12(1):99-102. PubMed ID: 21517239
[TBL] [Abstract][Full Text] [Related]
2. KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells.
Li J; Chen Q; Deng Z; Chen X; Liu H; Tao Y; Wang X; Lin S; Liu N
Life Sci; 2019 May; 224():255-262. PubMed ID: 30928404
[TBL] [Abstract][Full Text] [Related]
3. Clusterin confers paclitaxel resistance in cervical cancer.
Park DC; Yeo SG; Shin EY; Mok SC; Kim DH
Gynecol Oncol; 2006 Dec; 103(3):996-1000. PubMed ID: 16890274
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells.
Lee KH; Yim EK; Kim CJ; Namkoong SE; Um SJ; Park JS
Gynecol Oncol; 2005 Jul; 98(1):45-53. PubMed ID: 15907983
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis reveals potential candidate drugs for cervical cancer.
Ai Z; Wang J; Xu Y; Teng Y
J Obstet Gynaecol Res; 2013 May; 39(5):1052-8. PubMed ID: 23551598
[TBL] [Abstract][Full Text] [Related]
6. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
Blanchard Z; Paul BT; Craft B; ElShamy WM
Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
[TBL] [Abstract][Full Text] [Related]
7. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
8. Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells.
Liu B; Fang M; Lu Y; Lu Y; Mills GB; Fan Z
Br J Cancer; 2001 Jul; 85(2):303-11. PubMed ID: 11461094
[TBL] [Abstract][Full Text] [Related]
9. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.
MacKeigan JP; Taxman DJ; Hunter D; Earp HS; Graves LM; Ting JP
Clin Cancer Res; 2002 Jul; 8(7):2091-9. PubMed ID: 12114408
[TBL] [Abstract][Full Text] [Related]
11. [Paclitaxel induced apoptotic genes and pathways alterations: a review].
Liu D; Kang H; Sun C; Xiao Y; Zhao K
Sheng Wu Gong Cheng Xue Bao; 2013 Feb; 29(2):153-60. PubMed ID: 23697160
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel reversed trastuzumab resistance via regulating JUN in human gastric cancer cells identified by FAN analysis.
Wang Z; Zou F; Tian Y; Xiang B; Qin B; Liu Y
Future Oncol; 2018 Nov; 14(26):2701-2712. PubMed ID: 30265158
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MEK sensitizes paclitaxel-induced apoptosis of human colorectal cancer cells by downregulation of GRP78.
Mhaidat NM; Alali FQ; Matalqah SM; Matalka II; Jaradat SA; Al-Sawalha NA; Thorne RF
Anticancer Drugs; 2009 Aug; 20(7):601-6. PubMed ID: 19521235
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways.
Wang TH; Chan YH; Chen CW; Kung WH; Lee YS; Wang ST; Chang TC; Wang HS
Oncogene; 2006 Aug; 25(35):4857-66. PubMed ID: 16547493
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of taxol-resistant nasopharyngeal carcinoma cells with siRNA-mediated FOLR1 downregulation.
Song Y; Peng X; Wang M; Xie J; Tan G
Int J Clin Exp Pathol; 2015; 8(9):11314-22. PubMed ID: 26617855
[TBL] [Abstract][Full Text] [Related]
16. Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.
Lamendola DE; Duan Z; Yusuf RZ; Seiden MV
Cancer Res; 2003 May; 63(9):2200-5. PubMed ID: 12727840
[TBL] [Abstract][Full Text] [Related]
17. Research on chemotherapy efficacy of twist gene on cervical cancer cells to paclitaxel.
Sun Z; Zhang D; Cui Y; Cheng L; Cao J; Wu X
Pak J Pharm Sci; 2014 Sep; 27(5 Suppl):1713-8. PubMed ID: 25262524
[TBL] [Abstract][Full Text] [Related]
18. Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3.
Oliveras-Ferraros C; Fernández-Arroyo S; Vazquez-Martin A; Lozano-Sánchez J; Cufí S; Joven J; Micol V; Fernández-Gutiérrez A; Segura-Carretero A; Menendez JA
Int J Oncol; 2011 Jun; 38(6):1533-47. PubMed ID: 21455577
[TBL] [Abstract][Full Text] [Related]
19. TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer.
Zhang SF; Wang XY; Fu ZQ; Peng QH; Zhang JY; Ye F; Fu YF; Zhou CY; Lu WG; Cheng XD; Xie X
Autophagy; 2015; 11(2):225-38. PubMed ID: 25607466
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]